One of the hot topics in the industry is the impact of PBS reforms. Can you speak to recent influence of PBS reforms affecting Novotech’s…

Many MNCs are having pipeline concerns in the “new era” of post-blockbuster drug development. How is Bayer positioned in this respect?…

The Ministry for Innovation, Industry, Science and Research was created in December 2007 with the election of the Labor government. To begin, would…

Would you please introduce Pierre Fabre to our readers? Pierre Fabre Medicament Australia Pty Limited was established in Australia in late 2001, and…

The Australian pharmaceutical sector has seen recent innovations through PBS reform and various working groups shaping the future of the industry. Can…

What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare &…

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry…

What impact have the PBS reforms had on Nycomed? As most mid size Pharma companies that operate in a setting of mass market prescription medicines,…

How have your experiences at Quintiles, Astra, Baxter, and Innovex – covering the spectrum from small to large pharma in addition to the service…

Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international…

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents…

Servier was eligible to receive $7 million in P3 funding; can you tell us how this initiative has helped the company? P3 was not one of the main…